Biotech Stock Roundup: Celgene Submits MS Drug to FDA, INSY & CB...

06/12/19

Biotech Stock Roundup: Celgene Submits MS Drug to FDA, INSY & CBAY Crash  Yahoo Finance

The biotech sector was back in focus this week with quite a few regulatory updates. While Celgene's CELG multiple sclerosis (MS) drug was submitted for ...

[more]